Building Blocks
This section contains fundamental products for the synthesis of organic and biological compounds. Building blocks are the essential starting materials used to construct complex molecules through various chemical reactions. They play a critical role in drug discovery, material science, and chemical research. At CymitQuimica, we offer a diverse range of high-quality building blocks to support your innovative research and industrial projects, ensuring you have the essential components for successful synthesis.
Subcategories of "Building Blocks"
- Boronic Acids & Boronic Acid Derivatives(5,756 products)
- Chiral Building Blocks(1,242 products)
- Hydrocarbon Building Blocks(6,093 products)
- Organic Building Blocks(60,522 products)
Found 195533 products of "Building Blocks"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Octahydro-1H-isoindol-4-ol
CAS:<p>Octahydro-1H-isoindol-4-ol is a potent, cisplatin-like antagonist of tachykinin receptors. It has high affinity for the NK2 receptor and low affinity for the NK1 receptor. Octahydro-1H-isoindol-4-ol also has an antiemetic effect in rats that is not blocked by the NK1 receptor antagonist, piperidine. The dose range for octahydro-1H-isoindol-4-ol is from low doses to high doses. The drug has been shown to be potent in animal studies; it had a 50% inhibitory concentration (IC50) of 0.2 nM for the rat NK2 receptor, which is lower than cisplatin's IC50 of 2 nM. In human cells, octahydro-1H-isoindol-4-ol inhibited the binding of [3H]neurokinin A</p>Formula:C8H15NOPurity:Min. 95%Molecular weight:141.21 g/mol2H,3H,5H,6H,7H,8H-[1,2,4]Triazolo[4,3-a]pyridin-3-one
CAS:<p>The invention relates to a combination of two or more triazolopyridines, wherein the individual compounds are selected from the group consisting of 2H,3H,5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyridin-3-one and pharmaceutically acceptable salts thereof. This invention also relates to a pharmaceutical composition comprising the combination of two or more triazolopyridines as well as a pharmaceutically acceptable carrier. This invention also relates to methods for treating lung inflammation by administering a therapeutically effective amount of the combination of two or more triazolopyridines. This invention also relates to methods for prophylaxis against lung inflammation by administering an effective amount of the combination of two or more triazolopyridines.</p>Formula:C6H9N3OPurity:Min. 95%Molecular weight:139.16 g/mol7-Bromo-[1,3]thiazolo[4,5-c]pyridin-2-amine
CAS:<p>Versatile small molecule scaffold</p>Formula:C6H4BrN3SPurity:Min. 95%Molecular weight:230.09 g/mol7-Oxo-2H,3H,7H-[1,3]oxazolo[3,2-a]pyrimidine-6-carbonitrile
CAS:<p>Versatile small molecule scaffold</p>Formula:C7H5N3O2Purity:Min. 95%Molecular weight:163.13 g/mol4-Chloro-2-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidine
CAS:<p>Versatile small molecule scaffold</p>Formula:C8H9N2ClPurity:Min. 95%Molecular weight:168.62 g/mol2-Hydrazinyl-5,6,7,8-tetrahydroquinazolin-4-ol
CAS:<p>Versatile small molecule scaffold</p>Formula:C8H12N4OPurity:Min. 95%Molecular weight:180.21 g/mol2-Hydroxymethyl-5-nitrophenylboronic acid dehydrated
CAS:<p>Versatile small molecule scaffold</p>Formula:C7H6BNO4Purity:Min. 95%Molecular weight:178.94 g/mol4-[5-(Trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenol
CAS:<p>Versatile small molecule scaffold</p>Formula:C9H5F3N2O2Purity:Min. 95%Molecular weight:230.14 g/mol3-Bromo-2,5,6-trifluorobenzoic acid
CAS:<p>Versatile small molecule scaffold</p>Formula:C7H2BrF3O2Purity:Min. 95%Molecular weight:254.99 g/mol3-(Trifluoromethyl)benzenesulfinic acid sodium
CAS:<p>Versatile small molecule scaffold</p>Formula:C7H4F3NaO2SPurity:Min. 95%Molecular weight:232.16 g/mol5-Octyl-1,3,4-thiadiazol-2-amine
CAS:<p>Versatile small molecule scaffold</p>Formula:C10H19N3SPurity:Min. 95%Molecular weight:213.35 g/mol1-(2-Aminoethoxy)naphthalene hydrochloride
CAS:<p>Versatile small molecule scaffold</p>Formula:C12H14ClNOPurity:Min. 95%Molecular weight:223.7 g/mol5-(4-Aminobutyl)-2-sulfanylideneimidazolidin-4-one hydrochloride
CAS:<p>Versatile small molecule scaffold</p>Formula:C7H14ClN3OSPurity:Min. 95%Molecular weight:223.72 g/mol1H,3H,4H,6H,7H-Pyrano[3,4-c]pyridin-6-one
CAS:<p>Versatile small molecule scaffold</p>Formula:C8H9NO2Purity:Min. 95%Molecular weight:151.2 g/mol5-(1H-Imidazol-1-ylmethyl)-1H-pyrrole-2-carbaldehyde
CAS:<p>Versatile small molecule scaffold</p>Formula:C9H9N3OPurity:Min. 95%Molecular weight:175.19 g/mol5-Bromo-6-fluoroindoline-2,3-dione
CAS:<p>Versatile small molecule scaffold</p>Formula:C8H3BrFNO2Purity:Min. 95%Molecular weight:244.02 g/mol1,2-Diphenylpropan-2-amine
CAS:<p>1,2-Diphenylpropan-2-amine is a compound that is used in the clinical setting to treat epilepsy and other neurological disorders. It has been shown to have neuroprotective effects by decreasing the concentrations of Ca2+ in cells and may have anti-epileptic effects due to its ability to inhibit glutamate release. The molecular mechanism of action of 1,2-Diphenylpropan-2-amine has been studied using computational modeling and whole cell recordings. This drug also shows neuroprotective properties in animal models through chronic oral administration.</p>Formula:C15H17NPurity:Min. 95%Molecular weight:211.3 g/mol6-Hydroxy-1-methyl-1H-indazole
CAS:<p>Versatile small molecule scaffold</p>Formula:C8H8N2OPurity:Min. 95%Molecular weight:148.17 g/mol3-(4-Methoxyphenoxy)-1-propanesulfonyl chloride
CAS:<p>Versatile small molecule scaffold</p>Formula:C10H13ClO4SPurity:Min. 95%Molecular weight:264.73 g/molSodium 3-(prop-2-enamido)propanoate
CAS:<p>Versatile small molecule scaffold</p>Formula:C6H8NNaO3Purity:Min. 95%Molecular weight:165.12 g/mol
![2H,3H,5H,6H,7H,8H-[1,2,4]Triazolo[4,3-a]pyridin-3-one](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FTEA80167.webp&w=3840&q=75)
![7-Bromo-[1,3]thiazolo[4,5-c]pyridin-2-amine](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FTEA80175.webp&w=3840&q=75)
![7-Oxo-2H,3H,7H-[1,3]oxazolo[3,2-a]pyrimidine-6-carbonitrile](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FTEA80189.webp&w=3840&q=75)
![4-Chloro-2-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidine](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FTEA80240.webp&w=3840&q=75)
![4-[5-(Trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenol](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FTEA82815.webp&w=3840&q=75)
![1H,3H,4H,6H,7H-Pyrano[3,4-c]pyridin-6-one](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FTEA87291.webp&w=3840&q=75)
